Klebsiella oxytoca


Also found in: Wikipedia.

Klebsiella oxytoca

a species characterized by its ability to produce indole. Clinically it resembles Klebsiella pneumoniae; however, nosocomial strains tend to exhibit a greater propensity to develop antibiotic resistance.

Kleb·si·el·la ox·y·to·ca

(kleb-sē-el'ă ok-sē-tō'kă)
A bacterial species characterized by its ability to produce indole. Clinically, it resembles K. pneumoniae; however, nosocomial strains exhibit a greater propensity to develop antibiotic resistance.

Klebs,

Theodor Albrecht Edwin, German physician, 1834-1913.
Klebsiella - a genus of bacteria (family Enterobacteriaceae) that occurs in the respiratory, intestinal, and urogenital tracts of humans as well as in soil, water, and grain.
Klebs disease
Klebs-Loeffler bacillus - a species that causes diphtheria and produces a powerful exotoxin causing degeneration of various tissues, notably myocardium. Synonym(s): Corynebacterium diphtheriae
Klebsiella oxytoca
Klebsiella pneumoniae - Synonym(s): Friedländer bacillus
References in periodicals archive ?
It is also approved to treat adult patients with cIAI caused by susceptible Gram-negative microorganisms such as Bacteroides caccae, Bacteroides fragilis, Bacteroides ovatus, Bacteroides stercoris, Bacteroides thetaiotaomicron, Bacteroides uniformis, Bacteroides vulgatus, Citrobacter freundii, Enterobacter cloacae, Escherichia coli, Fusobacterium nucleatum, Klebsiella aerogenes, Klebsiella oxytoca, Klebsiella pneumoniae, Parabacteroides distasonis and Pseudomonas aeruginosa.
Out of 152 specimens different species identified in order of their frequency were; Klebsiella pneumoniae (59; 38.8%), Pseudomonas aeruginosa (46; 30.3%), Escherichia coli (36; 23.7%), Klebsiella oxytoca (4; 2.6%), Serratia marcescens (3; 2%), Enterobacter agglomerans (2; 1.3%) and Enterobacter cloacae (2; 1.3%) as shown in Figure 1.
In the US, the company's ZERBAXA 3g dose (ceftolozane 2g and tazobactam 1g) is indicated for treatment of patients 18 years and older with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by the following susceptible Gram-negative microorganisms: Enterobacter cloacae, Escherichia coli, Haemophilus influenzae, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Serratia marcescens.
Food and Drug Administration has approved Merck's supplemental New Drug Application for the use of ZERBAXA for the treatment of patients 18 years and older with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by the following susceptible Gram-negative microorganisms: Enterobacter cloacae, Escherichia coli, Haemophilus influenzae, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Serratia marcescens.
But three species- Klebsiella pneumoniae, Klebsiella oxytoca, and Providencia alcalifaciens- survived the longest, with Klebsiella pneumoniae and Klebsiella oxytoca surviving for more than 100 days.
asburiae 1 Klebsiella oxytoca Klebsiella oxytoca 1 Kosakonia cowanii Kosakonia cowanii 2 Paenibacillus pasadenensis Paenibacillus pasadenensis 1 Human isolates Historical human MALDI-TOF detected in 2017 isolates C.
Other microbes that can secrete these enzymes such as Enterobacter cloacae, Morganella morganii, Serratia marcescens, Klebsiella oxytoca, Providencia stuartii and Citrobacter amalonaticus were less widespread in the hospital environment (10/351, 2.8%) (Figure 1).
Detection and characterization of Amp C Beta Lactamases in indian clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca. Universal J Microbiol Res 2013; 1(2): 15-21.
Many laboratories have adopted CLSI guidelines and only attempted to detect ESBLs in Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca and Proteus mirabilis.